首页> 外文OA文献 >Radiolabeled Antibody Fragment for Preparation of (177Lu-DOTA)_m-PAMAM G3.0-F(ab’)₂ trastuzumab as a Radiopharmaceutical for Cancer Therapy

【2h】

Radiolabeled Antibody Fragment for Preparation of (177Lu-DOTA)_m-PAMAM G3.0-F(ab’)₂ trastuzumab as a Radiopharmaceutical for Cancer Therapy

机译：用于制备的放射性标记抗体片段（ 177 lu-dota）_{m -pamam g3.0-f（ab'）_{2 trastuzumab作为放射性药物对于癌症治疗}}

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
R.D. Haryuni; M. Ramli; T Triningsih; S Sutari;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Radiolabeling of trastuzumab with 177Lu via DOTA, a new radiopharmaceutical for radioimmunotherapy of breast cancer. [J] . Rasaneh S, Rajabi H, Babaei MH, Nuclear Medicine and Biology . 2009,第4期

机译：通过DOTA对曲妥珠单抗进行177 Lu放射性标记，DOTA是一种用于乳腺癌放射免疫疗法的新放射性药物。
2. Cancer Imaging with Radiolabeled Antibodies: New Advances with Technetium-99m-Labeled Monoclonal Antibody Faba€? Fragments, Especially CEA-Scan?? and Prospects for Therapy [J] . David M. Goldenberg, Malik Juweid, Robert M. Dunn, Journal of nuclear medicine technology . 1997,第1期

机译：带有放射性标记抗体的癌症成像：Tech 99m标签单克隆抗体Faba的新进展碎片，尤其是CEA扫描？和治疗的前景
3. Radiolabeling and in vitro evaluation of a TA-MUC1 specific monoclonal antibody and its corresponding single chain fragment with zirconium-89, scandium-44, and lutetium-177: Promising tools for diagnosis and therapy of breast cancer [J] . Klasen Benedikt, Stergiou Natascha, Moon Euy Sung, Journal of Labelled Compounds and Radiopharmaceuticals . 2019,第S1期

机译：对Ta-Muc1特异性单克隆抗体及其相应的单链片段的放射性标记和体外评价用锆 - 89，Scandium-44和Lutetium-177：乳腺癌的诊断和治疗有希望的工具
4. Preparation and characterization of Radiolabeled Antibodies for Targeted Therapy and Imaging [C] . Lee So-Young, Young-Don Hong, Sun-Ju Choi Controlled Release Society Annual Meeting and Exposition . 2007

机译：靶向治疗和成像用放射性标记抗体的制备和表征
5. Comparison of the Measured Biodistribution of 212Pb-Radiolabeled Monoclonal Antibodies (Trastuzumab) in Mice with 232Th and Progeny in Human Reticuloendothelial Tissue Measured Using Alpha Particle Track Autoradiographic Microdosimetry from Thorotrast [D] . Schneider, Nathaniel R. 2019

机译：用α粒子轨道放射性微型微量血管测量的232th和后代在钍术中测量的232次和后代的小鼠212pB-放射性标记的单克隆抗体（Trastuzumab）对小鼠的测量生物分布的比较
6. A Pretherapy Biodistribution and Dosimetry Study of Indium-111-Radiolabeled Trastuzumab in Patients with Human Epidermal Growth Factor Receptor 2-Overexpressing Breast Cancer [O] . Jeffrey Y.C. Wong, Andrew Raubitschek, Dave Yamauchi, -1

机译：铟-111-放射性标记曲妥珠单抗在人表皮生长因子受体2-过表达乳腺癌患者中的治疗前生物分布和剂量学研究
7. Radiolabeled Antibody Fragment for Preparation of (177Lu-DOTA)m-PAMAM G3.0-F(ab\u27)2 Trastuzumab as a Radiopharmaceutical for Cancer Therapy [O] . Haryuni, R.D, Ramli, M, Triningsih, T, 2017

机译：放射性标记的抗体片段，用于制备（177Lu-DOTA）m-PAMAM G3.0-F（ab \ u27）2曲妥珠单抗，作为放射治疗癌症的药物
8. Radioimmunotherapy of Metastatic Breast Cancer Using Radiolabeled Tumor Specific Antibodies [R] . Wassweheit, C. 1998

机译：放射性标记的肿瘤特异性抗体对转移性乳腺癌的放射免疫治疗

Radiolabeled Antibody Fragment for Preparation of (177Lu-DOTA)m-PAMAM G3.0-F(ab’)2 trastuzumab as a Radiopharmaceutical for Cancer Therapy

著录项

相似文献

相关主题

期刊订阅

Radiolabeled Antibody Fragment for Preparation of (177Lu-DOTA)_m-PAMAM G3.0-F(ab’)₂ trastuzumab as a Radiopharmaceutical for Cancer Therapy